CtI

  CTI  enables providers, physicians and their patients to improve the diagnosis and treatment of cancer, heart disease and neurological disorders through innovative molecular imaging solutions.

Get in touch with us

About CTI Molecular Imaging

  • Ours is a journey of vision and innovation and now we are exploring a new path to opportunities that will expand PET technology and take it to a new molecular level launching the new paradigm in medicine - molecular medicine.


  • Inventing the future is a tradition at CTI Molecular Imaging. More than a generation ago, we envisioned a world in which PET technology would save lives by enabling physicians to detect and diagnose diseases earlier than ever before. And, we envisioned a world in which PET technology would improve lives by helping not only physicians but researchers plan and implement better, more accurate treatments. So we embarked on a journey of innovations, turned our visions into reality and became the industry leader in every facet of PET technology from basic science to the clinical care of patients.


  • We now envision a new generation of technologies that will define patient care as personalized, predictive, preventative and ultimately molecular. We also envision the development of gene imaging technologies that will make the diagnosis and treatment of diseases unique to each individual - just as their fingerprint. In the near future, our PET technology will help physicians explore these fingerprints of disease creating novel indicators as to when diseases will occur, how it should be treated and how patients will react to treatment.


Our Mission …

Compassion, technology, and innovation are at the center of everything we do. CTI’s mission has always focused on providing real life answers to patients, physicians and providers. 

Our Growth …

CTI has been responsible for the development of many of the major commercial innovations in PET since our formation in 1983. Recent innovations include inventing the combined PET/CT in 1998, and introducing the first commercial LSO scanners in 2001.

Our People …

CTI currently employs over 700 talented and skilled individuals with a variety of backgrounds, but we share a common commitment to our goal of making PET a clinical reality. 

Our Unique Environment …

Compassion, technology, and innovation are not just buzzwords at CTI – we live and breathe them. CTI has created a uniquely stimulating environment where every person plays an important role and makes their own important contributions to the company’s mission. 

Our Commitment …

Our role in PET is unique. Our people have the passion for PET, we have the technology to offer our health care providers; and we have the innovation to continue to lead the PET market to enhance patient care. PET is more than just a job to us; we are all committed to providing real life answers, and we believe we have a responsibility to achieve this goal. 

What is PET?

 Positron Emission Tomography (PET) is a powerful imaging technique that holds great promise in the diagnosis and treatment of many diseases, particularly cancer. A non-invasive test, PET scans accurately image the cellular function of the human body. In a single PET scan your physician can examine your entire body. PET scanning provides a more complete picture, making it easier for your doctor to diagnose problems, determine the extent of disease, prescribe treatment, and track progress.

What is PET/CT?

 ET (Positron Emission Tomography) and CT (Computed Tomography) scans are both standard imaging tools that physicians use to pinpoint disease states in the body. A PET scan demonstrates the biological function of the body before anatomical changes take place, while the CT scan provides information about the body's anatomy such as size, shape and location. By combining these two scanning technologies, a PET/CT scan enables physicians to more accurately diagnose and identify cancer, heart disease and brain disorders.


PET Scans for Cancer

What is Cancer?

PET can help physicians effectively pinpoint the source of cancer. This is possible because many cancer cells are highly metabolic and therefore synthesize the radioactive glucose (sugar) that is injected in the patient prior to the exam. The areas of high glucose uptake are dramatically displayed in the scan imagery, as opposed to the anatomical imagery of CT or MRI, which cannot detect active, viable tumors.


If cancer is found early, it can often be cured. A PET scan can be used in early diagnosis, assisting physicians in determining the best method for treatment. A whole body PET scan may detect whether cancer is isolated to one specific area or has spread to other organs before a treatment path is determined.


Approximately 1,372,910 new cancer cases are expected to be diagnosed in 2005. According to the American Cancer Society, approximately 570,280 Americans are expected to die of cancer this year, more than 1,560 people per day.


PET Scans and Cancer

Cancer comes in a variety of forms. Basically, cancer occurs when cells in the body begin to grow chaotically. Normally, cells grow, divide, and produce more cells to keep the body healthy and functioning properly. Sometimes, however, the process goes astray; cells keep dividing when new cells are not needed. Some types of cells are more prone to abnormal growth than others. The mass of extra cells forms a growth or tumor, which can be benign or malignant.


Benign tumors are not cancer. They often can be removed and, in most cases, they do not come back. Cells in benign tumors do not spread to other parts of the body. More importantly, benign tumors are rarely life threatening.


Malignant tumors are cancer. Cells in malignant tumors are abnormal and divide without control or order. These cancer cells can invade and destroy the tissue around them. In a process called metastasis, cancerous cells break away from the organs on which they are growing and travel to other parts of the body, where they continue to grow. Cells from cancerous ovaries, for example, commonly spread to the abdomen and nearby internal organs. Eventually, they can invade the bloodstream and lymph system (the two systems of vessels that bathe and feed all of the body's organs) and travel to organs throughout the body. Metastasis is how cancer "colonizes" to produce new tumors within the body.


PET Scanning for Heart Disease

What's Alzheimer ?

Alzheimer's disease is a disease that destroys brain cells. The destruction of cells causes a decline in mental functions that affect memory, thinking, language and behavior. Early symptoms may include difficulty in performing everyday tasks or remembering common words. Confusion and difficulty with reasoning are other frequent symptoms. As the disease progresses, victims of Alzheimer's disease become increasingly disoriented, anxious and agitated, until they can no longer perform the most basic tasks in their own care. While the disease can occur in people in their 40s and 50s, it most commonly affects those aged 65 and older.


PET and Alzheimer's

A PET scan can show the brain's biological changes attributable to Alzheimer's disease before any other diagnostic test. Alzheimer's disease can even be detected several years earlier than the onset of symptoms. Early detection and confirmation of Alzheimer's disease allows for:

Early drug therapy to slow the loss of the patient's ability to function.

Future planning before loss of mental capacity.

Positive and accurate diagnosis of other dementing processes, chronic depression and normal aging.

Help in the discovery and development of new therapies.

Hope.


Heart Disease: How Can PET Make a Difference?

PET scans of the heart make possible the study and quantification of various aspects of heart tissue function. Clinical studies show an important role for PET in diagnosing patients, describing disease and developing treatment strategy. Two areas of clinical application have emerged:


PET is the most accurate test to reveal whether or not a patient has coronary artery disease and impaired blood flow.

PET is the gold standard in determining the viability of heart tissue for revascularization. PET can determine if bypass surgery or a transplant would be the appropriate treatment.


The American Heart Association says the body will likely send one or more of these warning signals of a heart attack: uncomfortable pressure, fullness, squeezing or pain in the center of the chest lasting more than a few minutes; pain spreading to the shoulders, neck or arms; chest discomfort with lightheadedness, fainting, sweating, nausea or shortness of breath.

Heart disease is the leading killer of Americans today, and a heart attack is the most visible sign of heart disease. Looking at specific age groups, cardiovascular disease is No. 1 for age 65 and older; second for ages 25-64; third for ages 0-14; and fifth for ages 15-24. Heart disease is also the number one killer of American women.

The American Heart Association says the warning signs of stroke are: sudden numbness or weakness of face, arm or leg, especially on one side of the body; sudden confusion, trouble speaking or understanding; sudden trouble seeing in one or both eyes; sudden trouble walking, dizziness, loss of balance or coordination; sudden, severe headache with no known cause.

Patient Information

  • When dealing with cancer, heart disease, or brain disorders (such as Alzheimer’s), the earlier the diagnosis – the better the chance for successful treatment.


  • PET scans can detect very small cancerous tumors, and also see subtle changes in the brain and heart – long before other medical scans can.


Having a PET scan puts time on your side!

  • PET is a procedure (medical scan) that allows physicians to measure the body’s abnormal molecular cell activity to detect cancer, heart disease, and brain disorders, such as Alzheimer’s Disease.


  • PET scans are simple, painless and quick, offering patients and their families life-saving information that leads to early disease detection, diagnosis, and treatment.


  • PET and molecular imaging provides real life answers to better diagnose illness, guide treatment options and give patients ultimate control over their critical, life-saving health care decisions.


Start Now

 PET is a Clinical Reality

 

  • Positron emission tomography (PET) is a powerful, proven diagnostic imaging modality that displays the biological basis of function in the organ systems of the human body unobtainable through any other means.


  • PET effectively pinpoints the source of many of the most common cancers, heart and neurological diseases, providing physicians the pre-eminent diagnostic tool with which to guide treatment options.

PET reveals metastatic diseases other imaging techniques simply cannot detect.

PET shows the progress of disease and how the body responds to treatment.

PET has the potential to significantly reduce multiple medical costs and minimize pain to the patient.



CTI's Technology


PET technology offers distinct advantages over other modalities in the diagnosis and treatment of many diseases, particularly cancer, due to its ability to evaluate the body’s physiologic processes as a way to identify and manage the treatment of many abnormalities before anatomic changes are visible.


As a result, the worldwide PET imaging market is experiencing rapid growth due to significant clinical results in recent oncology studies and improved reimbursement trends, leading to higher adoption and utilization of PET.


Even with its high growth rate, PET has a long way to go to significantly penetrate the diagnostic imaging market. In 2001, approximately 250,000 PET scans were performed, compared to a total of 66 million procedures for CT, MRI, and nuclear studies.


The more particular important clinical applications for PET currently include the following:


  • Diagnosis and therapy management in oncology, specifically in lung, colorectal, melanoma, breast, lymphoma, and head and neck cancers,
  • Determination of cardiac tissue viability, and
  • Neurological disorders particularly Alzheimer’s, Parkinson’s, seizures, and other dementia disorders.






















CTI Provides the Total Solution in PET